Innoviva Inc (INVA) 11.79 $INVA Keryx (KERX) Stock Down

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Innoviva Inc (INVA) 11.79 $INVA

Keryx (KERX) Stock Down on Wider Q2 Loss, Supply Issues
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 8:17AM CDT
Keryx (KERX) announced disruption in the supply of Auryxia tablets along with disappointing second-quarter results.
ZTS: 52.54 (+0.25), INVA: 11.79 (-0.18), ANIP: 67.99 (-1.00), KERX: 4.37 (-0.09)

Tired of Bargain Hunting? Bet on 6 Stocks with Rising P/E
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 6:46AM CDT
Forget undervalued stocks, stocks with rising P/E also offer upside potential.
ZFGN: 3.09 (-0.11), GT: 29.18 (+0.06), INVA: 11.79 (-0.18), TI: 9.02 (-0.17), FBR: 6.52 (+0.06), DAC: 3.65 (-0.15)

Sanofi (SNY) Posts In-Line Q2 Earnings, Revenues Down Y/Y
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 4:19PM CDT
Sanofi (SNY) reported second-quarter 2016 business earnings of 74 cents per American Depositary Share, in line with the Zacks Consensus Estimate.
ZTS: 52.54 (+0.25), INVA: 11.79 (-0.18), ANIP: 67.99 (-1.00), SNY: 39.67 (-0.09)

Alkermes (ALKS) Posts Narrower Q2 Loss, Ups 2016 Outlook
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 10:06AM CDT
Alkermes (ALKS) reported a narrower-than-expected, second-quarter 2016 loss while revenues beat estimates; the company revised its outlook for 2016.
INVA: 11.79 (-0.18), FCSC: 1.02 (-0.01), ANIP: 67.99 (-1.00), ALKS: 44.39 (-0.86)

AstraZeneca (AZN) Beats on Q2 Earnings, Keeps 2016 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:16AM CDT
AstraZeneca (AZN) reported second-quarter 2016 core earnings of 83 cents per American Depositary Share, beating the Zacks Consensus Estimate of 42 cents.
INVA: 11.79 (-0.18), ANIP: 67.99 (-1.00), AZN: 33.56 (-0.01), NKTR: 17.26 (-0.46)

Innoviva Reports Second Quarter 2016 Financial Results
BusinessWire - Thu Jul 28, 3:05PM CDT
--U.S. TRx market share recently reached all-time highs of 10% for BREO and 8% for ANORO
INVA: 11.79 (-0.18)

Celgene (CELG) Tops Q2 Earnings & Revenues, Lifts View
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 11:11AM CDT
Celgene (CELG) reported better-than-expected second-quarter 2016 earnings and revenues; it once again raised the earnings outlook for 2016.
INVA: 11.79 (-0.18), FCSC: 1.02 (-0.01), ANIP: 67.99 (-1.00), CELG: 112.16 (+0.03)

Alexion (ALXN) Tops Q2 Earnings and Revenues (Revised)
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:33AM CDT
Alexion's (ALXN) second-quarter 2016 earnings of 93 cents per share surpassed the Zacks Consensus Estimate of 91 cents.
INVA: 11.79 (-0.18), ANIP: 67.99 (-1.00), ALXN: 132.13 (-0.30), NKTR: 17.26 (-0.46)

Glaxo (GSK) Beats Q2 Earnings Estimates, Revenues Up Y/Y
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:59AM CDT
Glaxo (GSK) reported second-quarter 2016 core earnings of 70 cents per American depositary share, beating the Zacks Consensus Estimate of 55 cents.
INVA: 11.79 (-0.18), ANIP: 67.99 (-1.00), GSK: 44.16 (-0.33), NVS: 81.34 (-0.60)

Bristol-Myers (BMY) Beats on Q2 Earnings, Lifts Outlook
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:43AM CDT
Bristol-Myers' (BMY) delivered better-than-expected second-quarter 2016 earnings and revenues; it raised the 2016 earnings outlook yet again.
INVA: 11.79 (-0.18), ANIP: 67.99 (-1.00), PFE: 34.98 (-0.21), BMY: 59.29 (+0.61)

Bayer (BAYRY) Beats on Q2 Earnings, Updates 2016 Outlook
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:10AM CDT
Bayer's (BAYRY) second-quarter 2016 core earnings of $2.34 per share topped estimates while revenues marginally missed expectations; it revised its 2016 outlook.
MON: 104.15 (+0.16), INVA: 11.79 (-0.18), ANIP: 67.99 (-1.00)

Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View
Arpita Dutt - Zacks Investment Research - Thu Jul 28, 7:02AM CDT
Amgen (AMGN) once again delivered a "beat and raise" quarter with growth products accounting for more than 50% of product sales.
BIIB: 316.81 (+3.43), INVA: 11.79 (-0.18), AMGN: 173.62 (-1.13), FMS: 44.68 (-1.74)

Vertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short
Arpita Dutt - Zacks Investment Research - Thu Jul 28, 6:13AM CDT
Although total revenues were just shy of expectations, Vertex's (VRTX) CF franchise sales improved sequentially.
BIIB: 316.81 (+3.43), VRTX: 98.01 (-1.09), INVA: 11.79 (-0.18), ANIP: 67.99 (-1.00)

Glaxo/Innoviva's Closed Triple Combination Tops Phase III
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 8:30AM CDT
Glaxo (GSK) and Innoviva (INVA) announced positive top-line data from the phase III FULFIL study on the closed triple combination therapy for the treatment of COPD.
INVA: 11.79 (-0.18), TBPH: 27.89 (-0.61), GSK: 44.16 (-0.33), BMY: 59.29 (+0.61)

Technical Snapshot on Application Software Stocks - Fortinet, Workday, Proofpoint, and Innoviva
PR Newswire - Thu Jun 09, 8:05AM CDT
On Wednesday, June 08, 2016, the NASDAQ Composite ended the trading session at 4,974.64, up 0.26%; the Dow Jones Industrial Average advanced 0.37% to finish at 18,005.05; and the S&P 500 closed at 2,119.12, up 0.33%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Fortinet Inc. (NASDAQ: FTNT), Workday Inc. (NYSE: WDAY), Proofpoint Inc. (NASDAQ: PFPT), and Innoviva Inc. (NASDAQ: INVA). Learn more about these stocks by accessing their free trade alerts at:
PFPT: 76.15 (+0.11), INVA: 11.79 (-0.18), WDAY: 82.08 (+0.71), FTNT: 34.90 (-0.17)

Glaxo/Innoviva Expedite Closed Triple Combination NDA Filing
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 8:40AM CDT
Glaxo (GSK) and Innoviva (INVA) will file an NDA in the U.S. for the closed triple combination therapy (FF/UMEC/VI) for the treatment of COPD by the end of 2016.
INVA: 11.79 (-0.18), TBPH: 27.89 (-0.61), GSK: 44.16 (-0.33), BMY: 59.29 (+0.61)

Regulatory update on US filing plans for closed triple combination therapy FF/UMEC/VI in patients with COPD
PR Newswire - Thu Jun 02, 10:00AM CDT
GlaxoSmithKline plc (LSE: GSK) and Innoviva, Inc. (Nasdaq: INVA) today announced that, following discussions with the US Food and Drug Administration (FDA), GSK has brought forward the plan to file a New Drug Application (NDA) in the US for the once-daily closed triple combination therapy, fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; a combination inhaled corticosteroid, longacting muscarinic antagonist, long-acting beta agonist) for patients with chronic obstructive pulmonary disease (COPD). The US regulatory submission is now anticipated by the end of 2016, rather than the first half of 2018, as previously expected.
INVA: 11.79 (-0.18), GSK: 44.16 (-0.33)

Regulatory Update on US Filing Plans for Closed Triple Combination Therapy FF/UMEC/VI in Patients With COPD
Marketwired - Thu Jun 02, 1:00AM CDT
Acceleration of Filing of US New Drug Application Now Expected by End of 2016
INVA: 11.79 (-0.18), GSK: 44.16 (-0.33)

Innoviva to Present at Jefferies 2016 Healthcare Conference on June 10
Marketwired - Wed Jun 01, 3:05PM CDT
SOUTH SAN FRANCISCO, CA--(Marketwired - Jun 1, 2016) -  Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar, Innoviva's President and Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference on Friday, June 10, at 11:00 a.m. ET at the Grand Hyatt Hotel, New York.
INVA: 11.79 (-0.18)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Shanghai Import Expo Draws 4,000 Global Companies Again

Updated Category News Views 132

Shanghai spent last week making a rather pointed commercial argument: China wants to be seen buying, not merely selling. The ninth China International Import Expo, or CIIE, brought together more than 4,000 overseas companies and participants from 162 countries, regions and international organizations. That is a serious gathering by any reasonable measure, even if the...

Continue Reading
Dario's WebMD Deal Opens a Vast, Unproven Channel Path

Updated Category News Views 85

One partnership can look like a gold mine from across the valley; getting the ore out is another matter entirely. DarioHealth has struck a strategic partnership with WebMD Health Services that could put its multi-condition care platform in front of an enormous commercial ecosystem: more than 3,500 employers and 65 million covered lives. That is a meaningful distribution...

Continue Reading
Getac's Linux Certification Matters at the Rugged Edge

Updated Category News Views 73

Field computers rarely get applause, but they can decide whether a critical operation runs cleanly or turns into a very expensive mess. Getac’s November 19 announcement that its UX10, G140, and V120 rugged devices are certified for Red Hat Enterprise Linux is not the sort of headline that sends investors pounding the table. It is, however, the kind of plumbing work that...

Continue Reading
Colossal's Halloween Campaign Wins Top Communicator Honor

Updated Category News Views 28

A horror-themed fan competition putting money toward hospitalized children is not the usual awards-season material, which is precisely why Colossal's latest recognition lands with some weight. The Phoenix-based professional fundraiser received an Award of Excellence, the top honor at the 32nd annual Communicator Awards, for its Face of Halloween campaign in the Innovation...

Continue Reading
AltaPointe PATH Outreach Puts Housing Waits in Focus

Updated Category News Views 0

Two years is a brutal length of time to ask somebody without stable housing to wait for an income-based apartment. That number hangs over AltaPointe Health's PATH program in Mobile, Alabama, and it ought to. The organization helped 16 people secure permanent housing in the past fiscal year, a figure that can look small if somebody is just skimming a report. It looks very...

Continue Reading
Barcelona Housing Summit Puts Affordability on the Map

Updated Category News Views 169

A packed Barcelona hall cannot magically unjam a housing market, but it can force the grown-ups in the room to stare at the mess. Housing World Summit, known as HOWS Barcelona, closed its first edition with 1,530 attendees and a broad cast: city officials, governments, developers, investors, third-sector groups and academics. That mix matters because affordable housing is...

Continue Reading
SciBase Sets Its 2027 AGM Nominating Committee Early

Updated Category News Views 59

Four names on a committee roster rarely make anyone pound the table, and they should not. Still, SciBase Holding has put an important bit of corporate housekeeping in place for its 2027 Annual General Meeting: the nominating committee that will handle shareholder-facing governance work ahead of the May 20 meeting in Stockholm. For a small listed medical-technology...

Continue Reading
Gene Editing’s Steady Revenue Engine Is Taking Shape

Updated Category News Views 87

Gene editing is finally starting to look less like a science-fair moonshot and more like a working supply chain. That distinction matters. The latest market estimate puts the global gene editing market at $5.23 billion in 2026 and projects $8.49 billion by 2031, a 10.1% compound annual growth rate. Respectable growth, certainly, but the real investment story is not a...

Continue Reading
MSD's AI Drug Bet Has Promise, but Plenty to Prove

Updated Category News Views 66

A promising molecule remains a very expensive guess until biology agrees. That is the sober lens for MSD's newly announced research collaboration with Isomorphic Labs: potentially meaningful science, certainly interesting strategic positioning, and absolutely no reason yet to start penciling in product sales. One Oncology Target, Not a Finished Drug On November 19, 2026,...

Continue Reading
AI Search Is Squeezing Clicks, Not Killing Content Yet

Updated Category News Views 121

A search result that answers the question before earning a click is a nasty little disruption, and marketers are plainly feeling around for solid ground. Goodfirms surveyed 192 content marketing professionals for its 2026 Content Engagement Metrics report, and the headline is more resilient than the prevailing panic: 66.3% said organic website traffic grew over the prior...

Continue Reading

Top 5 Most Recently Viewed Articles

EQT AB Faces Challenges Following UBS's Rating Cut

Updated Category News Views 124

EQT AB Stock Drops After UBS Downgrade Recently, shares of EQT AB (ST:EQTAB) took a hit as UBS decided to downgrade the stock from "neutral" to "sell." This change in outlook comes amid rising worries over valuation risks and anticipated earnings in the short term. Market Response and Current Trading Situation Following the downgrade, EQT AB saw its trading price dip by...

Continue Reading
AMTD's 'The Last Dance' Sets Record in Hong Kong Film Scene

Updated Category News Views 221

AMTD's Groundbreaking Film Success AMTD Group Inc., alongside its subsidiaries AMTD IDEA Group (NYSE: AMTD; SGX: HKB) and AMTD Digital Inc. (NYSE: HKD), has achieved a remarkable milestone in the film industry with its new release, 'The Last Dance.' This film has not only shattered nine major records in Hong Kong's cinematic landscape but has also surpassed the impressive...

Continue Reading
Community Healthcare Trust Boosts Q4 Dividend Reflecting Growth

Updated Category News Views 441

Community Healthcare Trust Increases Dividend for Fourth Quarter Community Healthcare Trust Incorporated (NYSE: CHCT) has recently made an exciting announcement regarding its upcoming dividend. This decision reflects the company's ongoing commitment to delivering value to its shareholders and demonstrates its robust financial health. Many investors eagerly await the news...

Continue Reading
NielsenIQ and OpenBrand Partner to Enhance Market Insights

Updated Category News Views 1043

NielsenIQ and OpenBrand Forge a Revolutionary Alliance NielsenIQ (NIQ) stands at the forefront of consumer intelligence, and their recent partnership with OpenBrand is set to redefine the landscape of market intelligence in the consumer electronics sector. This collaboration harnesses both companies' strengths to offer advanced solutions designed for retailers,...

Continue Reading
Florida Quantum Initiative Sparks Revolutionary Tech Development

Updated Category News Views 327

Florida Quantum Initiative Launched to Boost Technology Innovation MIAMI — Just recently, leaders from Florida's technology sector proclaimed the launch of Florida Quantum, a groundbreaking initiative designed to accelerate and organize the state's quantum economy. This exciting announcement came during the eMerge Americas' Tech Basel AI Summit Miami, showcasing...

Continue Reading